Literature DB >> 26071574

Placental pathologic changes in gestational diabetes mellitus.

Patrycja Jarmuzek1, Miroslaw Wielgos1, Dorota Bomba-Opon1.   

Abstract

Nowadays, the continuous rise of maternal obesity is followed by increased gestational diabetes mellitus incidence. GDM is associated with adverse fetal and neonatal outcome that often presents with macrosomia, birth trauma, neonatal hypoglycemia, and respiratory distress syndrome. Inclusion of GDM into 'the great obstetrical syndromes' emphasizes the role of the placenta in interactions of the maternal and fetal unit. The placenta acts as a natural selective barrier between maternal and fetal blood circulations. Placenta is sensitive to the hyperglycemic milieu and responses with adaptive changes of the structure and function. Alteration of the placental development and subsequent vascular dysfunction are presented in 6 out of 7 women with all ranges of diabetic severity. Most placentas from GDM pregnancies present typical histological findings such as villous immaturity, villous fibrinoid necrosis, chorangiosis, and increased angiogenesis. The type of dysfunction depends on how early in pregnancy glycaemia disorders occurred. Generally, if impaired glucose metabolism is diagnosed in the early pregnancy, mainly structural dysfunctions are observed. GDM that is detected in late gestation affects placental function to a greater extent. Moreover many studies suggest that diabetic placental changes are associated with inflammation and oxidative stress that can lead to the chronic fetal hypoxia. This article aims to review particular changes of the development, anatomy and function of the placenta in the environment of abnormal glucose metabolism which can establish the maternal-placental-fetal interface dysfunction as a potential source of adverse pregnancy outcomes. A detailed sequence of events that leads from hyperglycemia to placental dysfunction and subsequent pregnancy complications may become an important issue for further studies.

Entities:  

Mesh:

Year:  2015        PMID: 26071574

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  18 in total

1.  miRNA Profiles in Extracellular Vesicles From Serum Early in Pregnancies Complicated by Gestational Diabetes Mellitus.

Authors:  Virginie Gillet; Annie Ouellet; Yulia Stepanov; Rodosthenis S Rodosthenous; Erika Kathe Croft; Kasey Brennan; Nadia Abdelouahab; Andrea Baccarelli; Larissa Takser
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

Review 2.  Metabolic abnormalities and obesity's impact on the risk for developing preeclampsia.

Authors:  Frank T Spradley
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-11-30       Impact factor: 3.619

3.  Pancreatic prolactin receptor signaling regulates maternal glucose homeostasis.

Authors:  Jackson Nteeba; Kaiyu Kubota; Wenfang Wang; Hao Zhu; Jay Vivian; Guoli Dai; Michael Soares
Journal:  J Endocrinol       Date:  2019-02-01       Impact factor: 4.286

4.  Temporal trends in prenatal risk factors for the development of infantile hemangiomas.

Authors:  Jennifer J Schoch; Manrup K Hunjan; Katelyn R Anderson; Christine M Lohse; Jennifer L Hand; Dawn M R Davis; Megha M Tollefson
Journal:  Pediatr Dermatol       Date:  2018-09-06       Impact factor: 1.588

5.  Nrf2 signalling and autophagy are involved in diabetes mellitus-induced defects in the development of mouse placenta.

Authors:  Mei-Yao He; Guang Wang; Sha-Sha Han; Ya Jin; He Li; Xia Wu; Zheng-Lai Ma; Xin Cheng; Xiuwen Tang; Xuesong Yang; Guo-Sheng Liu
Journal:  Open Biol       Date:  2016-07       Impact factor: 6.411

6.  Screening of gestational diabetes mellitus in early pregnancy by oral glucose tolerance test and glycosylated fibronectin: study protocol for an international, prospective, multicentre cohort trial.

Authors:  E A Huhn; T Fischer; C S Göbl; M Todesco Bernasconi; M Kreft; M Kunze; A Schoetzau; E Dölzlmüller; W Eppel; P Husslein; N Ochsenbein-Koelble; R Zimmermann; E Bäz; H Prömpeler; E Bruder; S Hahn; I Hoesli
Journal:  BMJ Open       Date:  2016-10-12       Impact factor: 2.692

7.  GDM-Induced Macrosomia Is Reversed by Cav-1 via AMPK-Mediated Fatty Acid Transport and GLUT1-Mediated Glucose Transport in Placenta.

Authors:  Guo Yao; Yafang Zhang; Di Wang; Ruirui Yang; Hui Sang; Linlin Han; Yuexia Zhu; Yanyan Lu; Yeke Tan; Zhanping Shang
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

8.  High glucose suppresses the viability and proliferation of HTR‑8/SVneo cells through regulation of the miR‑137/PRKAA1/IL‑6 axis.

Authors:  Hai-Yan Peng; Ming-Qing Li; Hua-Ping Li
Journal:  Int J Mol Med       Date:  2018-05-17       Impact factor: 4.101

9.  Genetic determinants of pig birth weight variability.

Authors:  Xuemin Wang; Xiaolei Liu; Dadong Deng; Mei Yu; Xiaoping Li
Journal:  BMC Genet       Date:  2016-01-27       Impact factor: 2.797

Review 10.  Insulin Is a Key Modulator of Fetoplacental Endothelium Metabolic Disturbances in Gestational Diabetes Mellitus.

Authors:  Luis Sobrevia; Rocío Salsoso; Bárbara Fuenzalida; Eric Barros; Lilian Toledo; Luis Silva; Carolina Pizarro; Mario Subiabre; Roberto Villalobos; Joaquín Araos; Fernando Toledo; Marcelo González; Jaime Gutiérrez; Marcelo Farías; Delia I Chiarello; Fabián Pardo; Andrea Leiva
Journal:  Front Physiol       Date:  2016-03-31       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.